IP Library Granted Patent US 7,053,045
Granted Patent B2
US 7,053,045 · App. 10/837,624 · Granted May 30, 2006

Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,053,045
App. No.
10/837,624
Granted
May 30, 2006
Kind
B2
Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the nuclear hormone receptor peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the nuclear hormone receptor peptides, and methods of identifying modulators of the nuclear hormone receptor peptides.

Claims (12)

1. An isolated polypeptide, wherein the amino acid sequence of said polypeptide consists of SEQ ID NO:2.

2. An isolated polypeptide, wherein the amino acid sequence of said polypeptide comprises SEQ ID NO:2.

3. An isolated polypeptide, wherein the amino acid sequence of said polypeptide consists of SEQ ID NO:2 except that residue 237 of SEQ ID NO:2 is leucine.

4. An isolated polypeptide, wherein the amino acid sequence of said polypeptide comprises SEQ ID NO:2 except that residue 237 of SEQ ID NO:2 is leucine.

5. A fusion polypeptide, wherein the fusion polypeptide comprises the polypeptide of claim 2 fused to a heterologous amino acid sequence.

6. A fusion polypeptide, wherein the fusion polypeptide comprises the polypeptide of claim 4 fused to a heterologous amino acid sequence.

7. A composition comprising the polypeptide of claim 1 and a carrier.

8. A composition comprising the polypeptide of claim 2 and a carrier.

9. A composition comprising the polypeptide of claim 3 and a carrier.

10. A composition comprising the polypeptide of claim 4 and a carrier.

11. A composition comprising the fusion polypeptide of claim 5 and a carrier.

12. A composition comprising the fusion polypeptide of claim 6 and a carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →